Shin Nippon Biomedical Laboratories Ltd 2395.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
1,760.00quote price arrow up+110.00 (+6.67%)
Volume
1,345,500
52 week range
759.00 - 1,870.00
Loading...
  • Open1,650.00
  • Day High1,767.00
  • Day Low1,636.00
  • Prev Close1,650.00
  • 52 Week High1,870.00
  • 52 Week High Date11/22/21
  • 52 Week Low759.00
  • 52 Week Low Date06/10/21

Key Stats

  • Market Cap488.39M
  • Shares Out41.63M
  • 10 Day Average Volume834,190.91
  • Dividend40.00
  • Dividend Yield2.27%
  • Beta-
  • YTD % Change23.94

KEY STATS

  • Open1,650.00
  • Day High1,767.00
  • Day Low1,636.00
  • Prev Close1,650.00
  • 52 Week High1,870.00
  • 52 Week High Date11/22/21
  • 52 Week Low759.00
  • 52 Week Low Date06/10/21
  • Market Cap488.39M
  • Shares Out41.63M
  • 10 Day Average Volume834,190.91
  • Dividend40.00
  • Dividend Yield2.27%
  • Beta-
  • YTD % Change23.94

RATIOS/PROFITABILITY

  • EPS (TTM)103.30
  • P/E (TTM)17.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2022
  • Div Amount10.00
  • Split Date-
  • Split Factor-

Latest On Shin Nippon Biomedical Laboratories Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test...
Ryoichi Nagata
Chairman of the Board, President, Chief Executive Officer, CHO, Representative Director
Ken Takanashi CPA
Chief Operating Officer, Vice President, Representative Director
Shinji Nitanda
Senior Managing Director, Chief Financial Officer
Address
28F, St Luke's Tower, 8-1, Akashi-cho
Chuo-ku, TKY
104-0044
Japan